What is ABT's current stock price?

As of now, ABT is trading at $124.84, with a daily change of +0.02%.

Market Overview Trending Stocks Stock Screener Trade Insights

Top Rated Stocks Most Active Stocks Top Potential Stocks Top Momentum Stocks Leaderboard

About Us Log In Sign Up Plans & Pricing Contact Us Terms of Use Privacy Policy

Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in My Watchlist

ABT Stock Analysis & IQ Rating | Abbott Laboratories

ABT

Abbott Laboratories

$124.84

+$0.03 | +0.02%

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Headlines

52W High

$141.23

MKT CAP

$217.08B

52W Low

$110.86

VOL

$2.12M

P/E Ratio

15.59

AVG VOL

$6.73M

RSI

46.11

TREND

Downtrend

BQ Stock IQ

Login to see Abbott Laboratories (ABT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ABT Target Price

Login to display

Strengths

ABT Rewards

Earnings are forecast to grow

ABT Rewards

Upgraded on attractively valued

ABT Rewards

Outperform the market

ABT Rewards

Investors confidence is positive

ABT Price Performance

$128.11 (-2.55%)

$132.99 (-6.13%)

$130.93 (-4.65%)

$111.1 (+12.37%)

1year

6month

3month

1month

ABT Risk Level

ABT has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

ABT Analysts Opinion

ABT overall standing based on key factors, offering insights into analysts perspectives and market expectations.
menu Hover over the category for more information

ABT Analysts Opinion

ABT Analysts opinion is negative and it remained unchanged from the past 3 months

ABT Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

45%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

0%

ABT Street Sentiment

ABT Street Sentiment is bullish but have mixed views on the near-term outlook

ABT Performance Sentiment

Sentiments overview associated with ABT events and the stock performance.

45%

5%

Positive

Negative

9 out of 20
events present

1 out of 20
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$124.81

Resistance
Price

$123.62

Current Price Range

$127.66

Show methods +

Linked to ABT

IQ

Close Price

Change

MRK

4.22

106.78

+0.31%

CVKD

2.05

7.41

+0.54%

PFE

3.73

25.09

+0.24%

AZN

4.13

92.90

+0.49%

OGN

3.61

7.18

+1.27%

ABT Latest Analysis +

Peter Lynch Detailed Fundamental Analysis - ABT. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Fri Dec 26, 2025

$124.84 | +0.02%

Potential

Abbott Laboratories Shrugs Off Tariffs And China Headwinds With A 7% Dividend Raise.

Wed Dec 24, 2025

$124.81 | +0.22%

Potential

FDA Clears Abbotts Volt PFA System For AFib Expanding US Treatment Options. On Monday the United States Food and Drug Administration (FDA) approved ABT) Volt PFA System to treat patients .AFib is the most common type of irregular heart rhythm (arrhythmia) where the heart’.s upper chambers (atria) quiver rapidly and chaotically instead of beating effectively leading to a fast irregular pulse palpitations shortness of breath and fatigue and significantly increasing the risk of blood clots str

Mon Dec 22, 2025

$125.20 | -0.17%

Activity

Abbott wins FDA approval of Volt pulsed ablation device for atrial fibrillation.

Mon Dec 22, 2025

$125.20 | -0.17%

Activity

Peter Lynch Detailed Fundamental Analysis - ABT. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Mon Dec 22, 2025

$125.20 | -0.17%

Potential

Abbott Wins FDA Approval For Volt Heart Rhythm Treatment . (RTTNews) - Abbott (ABT) announced on Monday that the United States Food and Drug Administration has approved its Volt Pulsed Field Ablation (PFA) system for treating atrial fibrillation paving the way for commercial use of the device in the United States.

Mon Dec 22, 2025

$125.20 | -0.17%

Activity

Peter Lynch Detailed Fundamental Analysis - ABT. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Fri Dec 19, 2025

$125.45 | +0.26%

Potential

ABT Factor-Based Stock Analysis - Peter Lynch. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Wed Dec 17, 2025

$126.71 | -0.12%

Potential

Abbott Laboratories (ABT) Shares Cross 2% Yield Mark. Looking at the universe of stocks we cover at Dividend Channel in trading on Wednesday shares of Abbott Laboratories (Symbol: ABT) were yielding above the 2% mark based on its quarterly dividend (annualized to $2.52) with the stock changing hands as low as $125.94 on the day.

Wed Dec 17, 2025

$126.71 | -0.12%

Activity

CELEBRATING A DECADE AUTOTECH VENTURES ADDS MIKE ABBOTT AS VENTURE PARTNER ELEVATES SENIOR LEADERS DOUBLES DOWN ON AI AND DEEP TECH. MENLO PARK Calif. Dec. 17 2025 /PRNewswire/ -- Autotech Ventures an early- and growth-stage venture capital firm celebrates its 10th anniversary as one of the most active sector-focused investors in transportation logistics and industrial systems. Team Expansion As part of its...

Wed Dec 17, 2025

$126.71 | -0.12%

Activity

FAQ About ABT Stock Insights

What is ABT current stock price?

What are ABT stock strengths?

What is ABT Risk Level?

What is ABT market cap and volume?

What is ABT current Stock IQ?

Should I buy ABT stock right now?

Is ABT a Strong Buy right now?

What does a 'Strong Buy' rating mean for ABT?

What does a 'Strong Sell' rating mean for ABT?

What factors influence ABT's Stock IQ?

Explore our ABT Stock insights

In-Depth Market Analysis and Trends
Expert Insights on Market Dynamics
Tailored ABT Stock Strategies
Effective Risk Management

FIND US ON

Receive our ABT Daily Alerts

Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts

Market Trends

Stay ahead of the market

Market trends

Investment tips

Market analysis service

Investment Insights

Future potential

Informed investment decisions

Investment analysis

IInvestment strategies

Stock Analysis

In-depth stock analysis

Performance analysis

Stock market insights

Financial trends analysis

ABT

Abbott Laboratories

Current Price

$124.84

+$0.03 | +0.02%

52W High

$141.23

MKT CAP

$217.08B

52W Low

$110.86

VOL

$2.12M

P/E Ratio

15.59

AVG VOL

$6.73M

RSI

46.11

TREND

Downtrend

Set Alerts

Overview

Comments

Insights

Risks

Rating

Chart

Analysts

Street

Sentiment

Target Price

Login to display

Not Enough Information

Stock Insights

Strengths

ABT Rewards

Earnings are forecast to grow

ABT Rewards

Upgraded on attractively valued

ABT Rewards

Outperform the market

ABT Rewards

Investors confidence is positive

Linked to ABT

Symbol

IQ

Close

Change

MRK

4.22

106.78

+0.31%

CVKD

2.05

7.41

+0.54%

PFE

3.73

25.09

+0.24%

AZN

4.13

92.90

+0.49%

OGN

3.61

7.18

+1.27%

ABT Price Performance

$128.11 (-2.55%)

$132.99 (-6.13%)

$130.93 (-4.65%)

$111.1 (+12.37%)

1year

6month

3month

1month

ABT Analysts Opinion

ABT Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
menu Hover over the category for more information

ABT Analysts Opinion

ABT Analysts opinion is negative and it remained unchanged from the past 3 months

ABT Street Sentiment

Analysts perspectives on the stock desirability, trend direction and growth potential

45%

Buy
Opinion

Trend
Score

Potential
Score

Consensus Rating

100%

0%

ABT Street Sentiment

ABT Street Sentiment is bullish but have mixed views on the near-term outlook

ABT Risk Level

ABT has Low risk level based on volatility, sector strength, volume, investor confidence and outlook.

Click here to check what is your level of risk

Low

LOW

HIGH

ABT Performance Sentiment

Sentiments overview associated with ABT events and the stock performance.

45%

5%

Positive

Negative

9 out of 20
events present

1 out of 20
events present

Very Bullish

Bullish

Neutral

Bearish

Very Bearish

Technical Price Levels

Average key support and resistance price levels

Support
Price

$124.81

Resistance
Price

$123.62

Current Price Range

$127.66

Show methods +

ABT Stock IQ

Login to unlock Abbott Laboratories (ABT) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid

ABT Latest Analysis

Peter Lynch Detailed Fundamental Analysis - ABT. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Fri Dec 26, 2025

$124.84 | +0.02%

Potential

Abbott Laboratories Shrugs Off Tariffs And China Headwinds With A 7% Dividend Raise.

Wed Dec 24, 2025

$124.81 | +0.22%

Potential

FDA Clears Abbotts Volt PFA System For AFib Expanding US Treatment Options. On Monday the United States Food and Drug Administration (FDA) approved ABT) Volt PFA System to treat patients .AFib is the most common type of irregular heart rhythm (arrhythmia) where the heart’.s upper chambers (atria) quiver rapidly and chaotically instead of beating effectively leading to a fast irregular pulse palpitations shortness of breath and fatigue and significantly increasing the risk of blood clots str

Mon Dec 22, 2025

$125.20 | -0.17%

Activity

Abbott wins FDA approval of Volt pulsed ablation device for atrial fibrillation.

Mon Dec 22, 2025

$125.20 | -0.17%

Activity

Peter Lynch Detailed Fundamental Analysis - ABT. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Mon Dec 22, 2025

$125.20 | -0.17%

Potential

Abbott Wins FDA Approval For Volt Heart Rhythm Treatment . (RTTNews) - Abbott (ABT) announced on Monday that the United States Food and Drug Administration has approved its Volt Pulsed Field Ablation (PFA) system for treating atrial fibrillation paving the way for commercial use of the device in the United States.

Mon Dec 22, 2025

$125.20 | -0.17%

Activity

Peter Lynch Detailed Fundamental Analysis - ABT. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Fri Dec 19, 2025

$125.45 | +0.26%

Potential

ABT Factor-Based Stock Analysis - Peter Lynch. Below is Valideas guru fundamental report for ABBOTT LABORATORIES (ABT). Of the 22 guru strategies we follow ABT rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price relat

Wed Dec 17, 2025

$126.71 | -0.12%

Potential

Abbott Laboratories (ABT) Shares Cross 2% Yield Mark. Looking at the universe of stocks we cover at Dividend Channel in trading on Wednesday shares of Abbott Laboratories (Symbol: ABT) were yielding above the 2% mark based on its quarterly dividend (annualized to $2.52) with the stock changing hands as low as $125.94 on the day.

Wed Dec 17, 2025

$126.71 | -0.12%

Activity

CELEBRATING A DECADE AUTOTECH VENTURES ADDS MIKE ABBOTT AS VENTURE PARTNER ELEVATES SENIOR LEADERS DOUBLES DOWN ON AI AND DEEP TECH. MENLO PARK Calif. Dec. 17 2025 /PRNewswire/ -- Autotech Ventures an early- and growth-stage venture capital firm celebrates its 10th anniversary as one of the most active sector-focused investors in transportation logistics and industrial systems. Team Expansion As part of its...

Wed Dec 17, 2025

$126.71 | -0.12%

Activity

Discover ABT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of ABT. We're here to help you make informed investment decisions today.

FIND US ON

Receive our ABT Daily Alerts

Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts

Market trends

In-depth stock analysis

Informed investment decisions

Stock market insights

Stock trading tips

Stock analysis

ABT Stock trends

ABT Stock performance

ABT Stock analysis

ABT investment strategies

Stock strategies

Trading strategies

StocksRunner updates

StocksRunner Insights

Financial Reports

Disclaimer: Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor. The Readiness Indicators, Sentiment Indicators and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses. Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.

Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").

This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABT

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

✕

Don't Be a Sheep, Be a StocksRunner

StocksRunner Aggregates The Most Important Headlines Into A Single Stock IQ

Sign up for free and

continue analysing ABT

Signup to Stocksrunner

Already a Member? Click here to Login

Join us on this journey to revolutionize the way you approach investing. Together, let's navigate the stock market with clarity, confidence and cutting-edge intelligence.

ABT Stock Analysis & IQ Rating | Abbott Laboratories

BQ Stock IQ

ABT Target Price

ABT Risk Level

ABT Analysts Opinion

ABT Street Sentiment

ABT Performance Sentiment

Technical Price Levels

Explore our ABT Stock insights

Receive our ABT Daily Alerts

ABT Street Sentiment

ABT Risk Level

Technical Price Levels

Discover ABT Stock analysis and effective trading strategies with StocksRunner.com. Gain valuable insights into stock performance, market trends and the future potential of ABT. We're here to help you make informed investment decisions today.

Receive our ABT Daily Alerts

ABT Alerts